- Report
- November 2024
- 130 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- January 2025
- 170 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- August 2025
- 190 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- February 2025
- 120 Pages
Global
From €2189EUR$2,490USD£1,893GBP
- Report
- November 2024
- 155 Pages
Global
From €2197EUR$2,500USD£1,901GBP
- Report
- January 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- April 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- January 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- January 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- August 2025
- 189 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- September 2025
- 250 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 258 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- March 2025
- 85 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- October 2024
- 200 Pages
United States
From €2189EUR$2,490USD£1,893GBP
- Report
- January 2025
- 104 Pages
North America
From €3032EUR$3,450USD£2,623GBP
- Report
- March 2019
- 66 Pages
China
From €703EUR$800USD£608GBP
- Report
- May 2024
- 131 Pages
Global
From €5712EUR$6,499USD£4,941GBP
- Report
- May 2024
- 133 Pages
Global
From €5712EUR$6,499USD£4,941GBP
- Report
- July 2023
- 130 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- March 2022
- 76 Pages
Saudi Arabia
From €3076EUR$3,500USD£2,661GBP

Strabismus, also known as crossed eyes, is a condition in which the eyes do not align properly. It is a common condition in children, but can also occur in adults. It is usually treated with corrective lenses, such as glasses or contact lenses, or with surgery. In the optical market, strabismus is a major area of focus, as it affects a large portion of the population. Companies in the optical market are developing new technologies to diagnose and treat strabismus, such as computerized eye tracking systems and advanced imaging techniques. Additionally, companies are researching new treatments, such as botulinum toxin injections, to reduce the symptoms of strabismus.
Some companies in the strabismus market include Johnson & Johnson Vision Care, Inc., Bausch + Lomb, CooperVision, Inc., Essilor International, and Hoya Corporation. Show Less Read more